Description

(3β,8β,13β,14α,17β,18α,21β)-D:C-Friedo-B':A'-Neogammacer-9(11)-En-3-Ol Acetate CAS NO 5595-78-8 is a high-purity, semi-synthetic triterpenoid derivative, valued for its role as a critical intermediate in advanced pharmaceutical synthesis and biochemical research. Its complex, stereochemically defined structure makes it an essential building block for developing novel therapeutic agents and conducting structure-activity relationship (SAR) studies. This compound is primarily sought by research institutions and pharmaceutical companies engaged in the development of anti-inflammatory, antiviral, and anticancer drug candidates.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the multi-step synthesis of novel triterpenoid-based drug candidates targeting various therapeutic areas.
• Biochemical Research: Used as a reference standard and probe molecule in enzymatic studies and metabolic pathway investigations related to sterol biosynthesis.
• Medicinal Chemistry: Serves as a core scaffold for the design and synthesis of analogs to explore and optimize pharmacological activity and selectivity.
• Academic Research: Employed in university and institutional labs for fundamental studies in organic synthesis, natural product chemistry, and chemical biology.
• Process Development: Utilized in scaling up synthetic routes and optimizing production processes for related active pharmaceutical ingredients (APIs).
• Reference Material: Acts as a high-purity certified reference material (CRM) for analytical method development and quality control in pharmaceutical manufacturing.

Basic Information

Product Name	(3β,8β,13β,14α,17β,18α,21β)-D:C-Friedo-B':A'-Neogammacer-9(11)-En-3-Ol Acetate
CAS No.	5595-78-8
Molecular Formula	C32H52O2
Molecular Weight	468.76 g/mol
Synonyms	3β-Acetoxy-D:C-friedo-B':A'-neogammacer-9(11)-ene; 9(11)-Friedelene-3β-ol acetate; 3β-Acetoxyfriedel-9(11)-ene; Friedelan-9(11)-en-3β-yl acetate; Neogammacer-9(11)-en-3β-ol acetate; (3β)-3-(Acetyloxy)-D:C-friedo-B':A'-neogammacer-9(11)-ene; Gammacerane triterpenoid acetate derivative
EINECS	Contact for details

Quality Control

Our (3β,8β,13β,14α,17β,18α,21β)-D:C-Friedo-B':A'-Neogammacer-9(11)-En-3-Ol Acetate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, GC, and NMR, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical quality attributes. Our production adheres to cGMP guidelines where applicable, ensuring reliability for research and development purposes.

Storage

Preserve in a tightly closed container, protected from light. Store under an inert atmosphere (e.g., nitrogen or argon) at a controlled room temperature (15-25°C) to prevent oxidation and degradation. The container should be kept in a cool, dry, and well-ventilated area, away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 98.0%
Melting Point	Contact for details
Specific Rotation	Contact for details
Heavy Metals	< 10 ppm
Residual Solvents	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.